BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2204718)

  • 1. On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion.
    Bleeker H; Shung K; Barnhart J
    J Ultrasound Med; 1990 Aug; 9(8):461-71. PubMed ID: 2204718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A feasibility study on quantitating myocardial perfusion with Albunex, an ultrasonic contrast agent.
    Wilson B; Shung KK; Hete B; Levene H; Barnhart JL
    Ultrasound Med Biol; 1993; 19(3):181-91. PubMed ID: 8511824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial regional blood flow: quantitative measurement by computer analysis of contrast enhanced echocardiographic images.
    Mor-Avi V; David D; Akselrod S; Bitton Y; Choshniak I
    Ultrasound Med Biol; 1993; 19(8):619-33. PubMed ID: 8134967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of mitral flow assessment by echo-contrast ultrasound, part I: determination of the properties of echo-contrast agents.
    Herman B; Einav S; Vered Z
    Ultrasound Med Biol; 2000 Jun; 26(5):787-95. PubMed ID: 10942826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography.
    Keller MW; Glasheen W; Kaul S
    J Am Soc Echocardiogr; 1989; 2(1):48-52. PubMed ID: 2627424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-domain ultrasonic contrast blood flowmetry.
    Shung KK; Flenniken RR
    Ultrasound Med Biol; 1995; 21(1):71-8. PubMed ID: 7754580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast echocardiography: influence of ultrasonic machine settings, mixing conditions, and pressurization on pixel intensity and microsphere size of Albunex solutions in vitro.
    Ota T; Hillman ND; Craig D; Kisslo J; Smith PK
    J Am Soc Echocardiogr; 1997; 10(1):31-40. PubMed ID: 9046491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary air-filled albumin microspheres for myocardial blood flow measurement.
    Rovai D; Ghelardini G; Trivella MG; Björklund G; Nevola E; Taddei L; Distante A; L'Abbate A
    J Am Coll Cardiol; 1993 Dec; 22(7):2014-21. PubMed ID: 8245361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrasound scattering properties of Albunex microspheres].
    Takamoto T; Shiina T
    Nihon Rinsho; 1998 Apr; 56(4):871-5. PubMed ID: 9577600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadband measurement of the scattering-to-attenuation ratio for Albunex at 37 degrees C.
    Marsh JN; Hughes MS; Brandenburger GH; Miller JG
    Ultrasound Med Biol; 1999 Oct; 25(8):1321-4. PubMed ID: 10576274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans.
    Ten Cate FJ; Widimsky P; Cornel JH; Waldstein DJ; Serruys PW; Waaler A
    Circulation; 1993 Nov; 88(5 Pt 1):2123-7. PubMed ID: 8222106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doppler quantification of echo-contrast injections in vivo.
    Hartley CJ; Cheirif J; Collier KR; Bravenec JS; Mickelson JK
    Ultrasound Med Biol; 1993; 19(4):269-78. PubMed ID: 8346601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of renal blood flow with contrast ultrasonography.
    Aronson S; Wiencek JG; Feinstein SB; Heidenreich PA; Zaroff JG; Walker R; Roizen MF
    Anesth Analg; 1993 May; 76(5):964-70. PubMed ID: 8484552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic investigation of flow patterns in the perfused human placenta and their modulation by vasoactive agents with enhanced visualization by the ultrasound contrast agent Albunex.
    Abramowicz JS; Phillips DB; Jessee LN; Levene H; Parker KJ; Miller RK
    J Clin Ultrasound; 1999; 27(9):513-22. PubMed ID: 10525213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of contrast intensity during systole in the left ventricular cavity with the use of the contrast agent Albunex. An analysis of its correlation with pressure and velocity.
    Tiukinhoy S; Bhoopalam S; Winkelmann JW; Ammar K; Mangulabnan L; Reddy G; Fernandez A; Block R; Malhotra V; Feinstein S
    Invest Radiol; 1996 Jul; 31(7):415-22. PubMed ID: 8818781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pressure on intracardiac backscatter from microbubbles.
    Deng Y; Li C; Chang Q
    J Tongji Med Univ; 2001; 21(3):246-8. PubMed ID: 12539591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic lability of albumin microspheres.
    Vandenberg BF; Melton HE
    J Am Soc Echocardiogr; 1994; 7(6):582-9. PubMed ID: 7840985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro calculation of flow by use of contrast ultrasonography.
    Heidenreich PA; Wiencek JG; Zaroff JG; Aronson S; Segil LJ; Harper PV; Feinstein SB
    J Am Soc Echocardiogr; 1993; 6(1):51-61. PubMed ID: 8439423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of myocardial perfusion with second harmonic imaging--using intravenous injection of Albunex and Levovist].
    Hasegawa M; Saiki Y; Kayano H; Katagiri T
    Nihon Rinsho; 1998 Apr; 56(4):903-8. PubMed ID: 9577606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.